Abstract
ObjectivesThe study aimed to determine the incidence of hospital-related COVID-19 (HrCOVID-19) among chronic kidney disease (CKD) patients in a specialty medical center in the Philippines.MethodsA retrospective descriptive cross-sectional design with record review was done. The hospital’s list of confirmed COVID-19 was used to determine cases who developed signs and symptoms more than 14 days of hospital stay. Outcome categories, either discharged alive or mortality, were also identified.ResultsTwenty-nine patients were included, predominantly males (55%) with mean age of 47 ± 14 years. Length of hospital stay to HrCOVID-19 confirmation was 24 days. An overall incidence rate of 1.26% (95% CI: 0.84-1.80) was seen, and peaked at 2.35% (95% CI: 1.13 – 4.28) in June 2020. Overall mortality rate was 45%.ConclusionIncidence of HrCOVID-19 among CKD patients was low but has high mortality rates. Active identification, containment and prevention of in-hospital transmissions to achieve zero cases is desirable. ObjectivesThe study aimed to determine the incidence of hospital-related COVID-19 (HrCOVID-19) among chronic kidney disease (CKD) patients in a specialty medical center in the Philippines. The study aimed to determine the incidence of hospital-related COVID-19 (HrCOVID-19) among chronic kidney disease (CKD) patients in a specialty medical center in the Philippines. MethodsA retrospective descriptive cross-sectional design with record review was done. The hospital’s list of confirmed COVID-19 was used to determine cases who developed signs and symptoms more than 14 days of hospital stay. Outcome categories, either discharged alive or mortality, were also identified. A retrospective descriptive cross-sectional design with record review was done. The hospital’s list of confirmed COVID-19 was used to determine cases who developed signs and symptoms more than 14 days of hospital stay. Outcome categories, either discharged alive or mortality, were also identified. ResultsTwenty-nine patients were included, predominantly males (55%) with mean age of 47 ± 14 years. Length of hospital stay to HrCOVID-19 confirmation was 24 days. An overall incidence rate of 1.26% (95% CI: 0.84-1.80) was seen, and peaked at 2.35% (95% CI: 1.13 – 4.28) in June 2020. Overall mortality rate was 45%. Twenty-nine patients were included, predominantly males (55%) with mean age of 47 ± 14 years. Length of hospital stay to HrCOVID-19 confirmation was 24 days. An overall incidence rate of 1.26% (95% CI: 0.84-1.80) was seen, and peaked at 2.35% (95% CI: 1.13 – 4.28) in June 2020. Overall mortality rate was 45%. ConclusionIncidence of HrCOVID-19 among CKD patients was low but has high mortality rates. Active identification, containment and prevention of in-hospital transmissions to achieve zero cases is desirable. Incidence of HrCOVID-19 among CKD patients was low but has high mortality rates. Active identification, containment and prevention of in-hospital transmissions to achieve zero cases is desirable.
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
